OFS in Premenopausal Node+ Breast Cancer With Low Genomic Risk

Clinical trial NCT05333328 · RECRUITING

Trial details

NCT number: NCT05333328
Sponsor: Gangnam Severance Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Breast Cancer Estrogen Receptor Positive Tumor HER2-negative Breast Cancer Premenopausal Breast Cancer Node-positive Breast Cancer

Start date: 2023-02-06
Primary completion: 2031-01-01
Enrollment: 418

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.